SLN360
Silence Therapeutics
[]
$silence therapeutics plc [15s. delayed]: issued press release on november 05, 10:30:00: silence therapeutics presents new analysis from sln360 phase 1 single dose study in high lipoprotein(a) at the american heart association (aha) 2022 annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time